Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Perfusion
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Scholz, T.
Right arrow Articles by Aasen, A. O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholz, T.
Right arrow Articles by Aasen, A. O
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Veno-venous bypass in liver transplantation: heparin-coated perfusion circuits reduce the activation of humoral defense systems in an in vitro model

Tim Scholz

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Blindern

Rigmor Solberg

Department of Pharmacology, School of Pharmacy, Blindern

Cecilie Okkenhaug

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Vibeke Videm

Department of Immunology and Transfusion Medicine, Institute of Laboratory Medicine, The Regional Hospital, Norwegian Institute for Science and Technology, Trondheim

Michael J Gallimore

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Øystein Mathisen

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Thore Pedersen

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Tom E Mollnes

Department of Immunology and Transfusion Medicine, Nordland Central Hospital, Bodø and University of Tromsø, Oslo

Anstein Bergan

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Odd Søreide

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

Göran B Klintmalm

Transplantation Services, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, Texas

Ansgar O Aasen

Institute for Surgical Research and Surgical Department, Rikshospitalet-National Hospital, Oslo

We studied the effects of bypass circuit surface heparinization on kallikrein-kinin, coagulation, fibrinolytic and complement activation in a closed model system for simulating veno-venous bypass (VVBP) in orthotopic liver transplantation (OLT).

The circuits were identical to those in routine use during clinical OLT in our institution. Fresh whole human blood diluted 1: 2 with Ringer’s acetate was circulated at a non-pulsatile flow (2 l/min) and at a constant temperature (37.5°C) for 12 h. In 10 experiments, the entire inner surface of the circuits was coated with end-point attached heparin (HC). In the remaining 10, non-treated PVC tubing was used (NC). Components of the plasma kallikrein-kinin, coagulation, fibrinolytic and complement systems were analyzed using functional techniques (chromogenic peptide substrate assays) and enzyme immunoassays at baseline, 3 and 12 h.

Significant activation of the initial (C3bc) and terminal (TCC) components of the complement system were found in both the NC and HC groups after 3 and 12 h: C3bc: NC: baseline =4 (3.5-7.7), 3 h=17.3* (12.5-27), 12 h=31* (17.7-63.6), HC: baseline=4.9 (3.2-6.8), 3 h=9* (6-14.4), 12 h=13.7* (7.4-18.1). TCC: NC: baseline=0.4 (0.2-0.6), 3 h=5* (0.8-11.9), 12 h: 13.1* (4.2-25.7). HC: baseline=0.5 (0.1-0.6), 3 h=0.6* (0.1-0.8), 12 h=1.2* (0.3-2) AU/ml; median and range (*: p<0.05). The C3bc and TCC concentrations were significantly higher in the NC group at 3 and 12 h, compared to the HC group: C3bc (NC vs. HC group): 3 h,p<0.001; 12 h, p<0.001. TCC (NC vs. HC group): 3 h, p<0.001; 12 h, p<0.001. Significant increases in the values of thrombin-antithrombin complexes (p<0.003), prothrombin fragment 1+2 (p<0.006) and plasmin-{alpha}2-antiplasmin complexes (p=0.016) were found in the non-coated group, but not in the heparin-coated group during the observation period, showing that the coagulation and fibrinolytic systems were activated in the non-coated circuits.

We conclude that heparin-coating of the internal surface of the extracorporeal perfusion circuit used for VVBP reduces activation of the plasma cascade systems in a closed venous system in vitro.

Perfusion, Vol. 16, No. 4, 285-292 (2001)
DOI: 10.1177/026765910101600404


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?